G. Grouard, The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand, J. Exp. Med, vol.185, pp.1101-1111, 1997.

M. Colonna, G. Trinchieri, and Y. J. Liu, Plasmacytoid dendritic cells in immunity, Nat. Immunol, vol.5, pp.1219-1226, 2004.

D. Jarrossay, G. Napolitani, M. Colonna, F. Sallusto, and A. Lanzavecchia, Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells, Eur. J. Immunol, vol.31, pp.3388-3393, 2001.

N. Kadowaki and Y. J. Liu, Natural type I interferon-producing cells as a link between innate and adaptive immunity, Hum. Immunol, vol.63, pp.1126-1132, 2002.

S. S. Diebold, T. Kaisho, H. Hemmi, S. Akira, and C. Reis-e-sousa, Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA, Science, vol.303, pp.1529-1531, 2004.

F. Heil, Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8, Science, vol.303, pp.1526-1529, 2004.

H. Hemmi, A Toll-like receptor recognizes bacterial DNA, Nature, vol.408, pp.740-745, 2000.

Y. J. Liu, IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors, Annu. Rev. Immunol, vol.23, pp.275-306, 2005.

M. Gandini, Dengue Virus Activates Membrane TRAIL Relocalization and IFN-alpha Production by Human Plasmacytoid Dendritic Cells In Vitro and In Vivo, PLOS Neglected Trop. Dis, vol.7, p.2257, 2013.

A. W. Hardy, D. R. Graham, G. M. Shearer, and J. P. Herbeuval, HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha, Proc. Natl Acad. Sci. USA, vol.104, pp.17453-17458, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00177945

G. Stary, Plasmacytoid dendritic cells express TRAIL and induce CD4 þ T-cell apoptosis in HIV-1 viremic patients, Blood, vol.114, pp.3854-3863, 2009.

B. Drobits, Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells, J. Clin. Investig, vol.122, pp.575-585, 2012.

J. Banchereau and V. Pascual, Type I interferon in systemic lupus erythematosus and other autoimmune diseases, Immunity, vol.25, pp.383-392, 2006.

V. Pascual, L. Farkas, and J. Banchereau, Systemic lupus erythematosus: all roads lead to type I interferons, Curr. Opin. Immunol, vol.18, pp.676-682, 2006.

A. Benlahrech and S. Patterson, HIV-1 infection and induction of interferon alpha in plasmacytoid dendritic cells, Curr. Opin. HIV AIDS, vol.6, pp.373-378, 2011.

S. Davidson, S. Crotta, T. M. Mccabe, and A. Wack, Pathogenic potential of interferon alphabeta in acute influenza infection, Nat. Commun, vol.5, p.3864, 2014.

W. Cao, Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTORp70S6K pathway, Nat. Immunol, vol.9, pp.1157-1164, 2008.

S. Blomberg, M. L. Eloranta, M. Magnusson, G. V. Alm, and L. Ronnblom, Expression of the markers BDCA-2 and BDCA-4 and production of interferonalpha by plasmacytoid dendritic cells in systemic lupus erythematosus, Arthritis Rheum, vol.48, pp.2524-2532, 2003.

A. Mazzoni, Cutting edge: histamine inhibits IFN-alpha release from plasmacytoid dendritic cells, J. Immunol, vol.170, pp.2269-2273, 2003.

M. Gschwandtner, S. Mommert, B. Kother, T. Werfel, and R. Gutzmer, The histamine H4 receptor is highly expressed on plasmacytoid dendritic cells in psoriasis and histamine regulates their cytokine production and migration, J. Investig. Dermatol, vol.131, pp.1668-1676, 2011.

A. Bufe, K. Gehlhar, E. Grage-griebenow, and M. Ernst, Atopic phenotype in children is associated with decreased virus-induced interferon-alpha release, Int. Arch. Allergy Immunol, vol.127, pp.82-88, 2002.

N. Smith, M. Etheve-quelquejeu, and J. Herbeuval, CD4 and tumor necrosis factor-related apoptosis ligand (TRAIL) localization in HIV-stimulated plasmacytoid dendritic cells by three-dimensional microscopy, AIDS Res. Hum. Retroviruses, vol.30, pp.1158-1159, 2014.

W. J. Calhoun, Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge, Am. J. Respir. Crit. Care Med, vol.157, pp.1381-1389, 1998.

H. Stark and . In-de-gruyter-open, PDF ISBN, vol.13, p.978876560557, 2013.

N. G. Gubernator, Fluorescent false neurotransmitters visualize dopamine release from individual presynaptic terminals, Science, vol.324, pp.1441-1444, 2009.

A. Boasso, HIV inhibits CD4 þ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells, Blood, vol.109, pp.3351-3359, 2007.

R. Colisson, Free HTLV-1 induces TLR7-dependent innate immune response and TRAIL relocalization in killer plasmacytoid dendritic cells, Blood, vol.115, pp.2177-2185, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00456470

C. Gras, TRAIL protein localization in human primary T cells by 3D microscopy using 3D interactive surface plot: a new method to visualize plasma membrane, J. Immunol. Methods, vol.387, pp.147-156, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00844941

A. E. Pegg, Toxicity of polyamines and their metabolic products, Chem. Res. Toxicol, vol.26, pp.1782-1800, 2013.

O. Zirafi, Discovery and characterization of an endogenous CXCR4 antagonist, Cell Rep, vol.11, pp.737-747, 2015.

G. Thoma, Orally Bioavailable Isothioureas Block Function of the Chemokine Receptor CXCR4 In Vitro and In Vivo, J. Med. Chem, vol.51, pp.7915-7920, 2008.

W. L. Chuang, M. D. Christ, J. Peng, and D. L. Rabenstein, An NMR and molecular modeling study of the site-specific binding of histamine by heparin, chemically modified heparin, and heparin-derived oligosaccharides, Biochemistry, vol.39, pp.3542-3555, 2000.

A. C. Andrews and T. D. Lyons, Binding of histamine and antihistamine to bovine serum albumin by mediation with Cu(II), Science, vol.126, pp.561-562, 1957.

K. Pritschet, CD4 À and dynamin-dependent endocytosis of HIV-1 into plasmacytoid dendritic cells, Virology, vol.423, pp.152-164, 2012.

G. A. Donzella, AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor, Nat. Med, vol.4, pp.72-77, 1998.

P. Fitzgerald-bocarsly and E. S. Jacobs, Plasmacytoid dendritic cells in HIV infection: striking a delicate balance, J. Leukoc. Biol, vol.87, pp.609-620, 2010.

J. P. Herbeuval and G. M. Shearer, HIV-1 immunopathogenesis: how good interferon turns bad, Clin. Immunol, vol.123, pp.121-128, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00110852

F. J. Perez-cano, A. Franch, C. Castellote, and M. Castell, Immunomodulatory action of spermine and spermidine on NR8383 macrophage line in various culture conditions, Cell Immunol, vol.226, pp.86-94, 2003.

M. Zhang, L. V. Borovikova, H. Wang, C. Metz, and K. J. Tracey, Spermine inhibition of monocyte activation and inflammation, Mol. Med, vol.5, pp.595-605, 1999.

F. E. Simons and . Anaphylaxis, J. Allergy Clin. Immunol, vol.121, 2008.

R. A. Wilkinson, Novel compounds containing multiple guanide groups that bind the HIV coreceptor CXCR4, Antimicrob. Agents Chemother, vol.55, pp.255-263, 2011.

H. Kohara, Development of plasmacytoid dendritic cells in bone marrow stromal cell niches requires CXCL12-CXCR4 chemokine signaling, Blood, vol.110, pp.4153-4160, 2007.

L. Tassone, Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients, Blood, vol.116, pp.4870-4873, 2010.

T. Nagasawa, CXCL1 2/SDF-1 and CXCR4, Front. Immunol, vol.6, p.301, 2015.

T. Nagasawa, Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin, Proc. Natl Acad. Sci. USA, vol.93, pp.14726-14729, 1996.

C. Guiducci, TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus, Nature, vol.465, pp.937-941, 2010.

S. Zahn, Interferon-alpha stimulates TRAIL expression in human keratinocytes and peripheral blood mononuclear cells: implications for the pathogenesis of cutaneous lupus erythematosus, Br. J. Dermatol, vol.165, pp.1118-1123, 2011.

S. L. Rowland, Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model, J. Exp. Med, vol.211, pp.1977-1991, 2014.

P. Gurung, Immune unresponsiveness to secondary heterologous bacterial infection after sepsis induction is TRAIL dependent, J. Immunol, vol.187, pp.2148-2154, 2011.

E. B. Wilson and D. G. Brooks, Decoding the complexity of type I interferon to treat persistent viral infections, Trends Microbiol, vol.21, pp.634-640, 2013.

J. R. Teijaro, Persistent LCMV infection is controlled by blockade of type I interferon signaling, Science, vol.340, pp.207-211, 2013.

S. Davidson, M. K. Maini, and A. Wack, Disease-promoting effects of type I interferons in viral, bacterial, and coinfections, J. Interferon Cytokine Res, vol.35, pp.252-264, 2015.

Y. J. Crow, Type I interferonopathies: mendelian type I interferon up-regulation, Curr. Opin. Immunol, vol.32, pp.7-12, 2015.

E. Miller and N. Bhardwaj, Dendritic cell dysregulation during HIV-1 infection, Immunol. Rev, vol.254, pp.170-189, 2013.

B. Schmidt, B. M. Ashlock, H. Foster, S. H. Fujimura, and J. A. Levy, HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration, Virology, vol.343, pp.256-266, 2005.

M. L. Gougeon and J. P. Herbeuval, IFN-alpha and TRAIL: a double edge sword in HIV-1 disease?, Exp. Cell Res, vol.318, pp.1260-1268, 2012.

J. A. Fraietta, Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection, PLOS Pathog, vol.9, p.1003658, 2013.

S. Moir, T. W. Chun, and A. S. Fauci, Pathogenic mechanisms of HIV disease, Ann. Rev. Pathol, vol.6, pp.223-248, 2011.

G. Li, Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice, PLOS Pathog, vol.10, p.1004291, 2014.

A. Meier, Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1, Nat. Med, vol.15, pp.955-959, 2009.

M. Ries, K. Pritschet, and B. Schmidt, Blocking type I interferon production: a new therapeutic option to reduce the HIV-1-induced immune activation, Clin. Dev. Immunol, vol.2012, p.534929, 2012.

B. Debnath, S. Xu, F. Grande, A. Garofalo, and N. Neamati, Small molecule inhibitors of CXCR4, Theranostics, vol.3, pp.47-75, 2013.

N. Smith, P. O. Vidalain, S. Nisole, and J. P. Herbeuval, An efficient method for gene silencing in human primary plasmacytoid dendritic cells: silencing of the TLR7/IRF-7 pathway as a proof of concept, Sci. Rep, vol.6, p.29891, 2016.

C. Hounsou, Time-resolved FRET binding assay to investigate heterooligomer binding properties: proof of concept with dopamine D1/D3 heterodimer, ACS Chem. Biol, vol.10, pp.466-474, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01950133

Y. Cheng and W. H. Prusoff, Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction, Biochem. Pharmacol, vol.22, pp.3099-3108, 1973.

J. M. Zwier, A fluorescent ligand-binding alternative using Tag-lite(R) technology, J. Biomol. Screen, vol.15, pp.1248-1259, 2010.